Top Story

TB rates declining among US children, but disparities persist

August 22, 2019

Read the Perspective from Jeffrey R. Starke, MD

FDA News

Pretomanid, first TB drug developed by non-profit, gets FDA approval for resistant infections

August 14, 2019
The FDA has approved pretomanid — the first tuberculosis drug developed by a non-profit organization — as part of a three-drug regimen for the treatment of…
In the Journals

Estimated global prevalence of latent TB about 25%

July 31, 2019
About one-quarter of the world’s population may be infected with latent tuberculosis, according to a systematic review and meta-analysis published in the European

NIH launches delamanid trial for MDR-TB prevention

June 28, 2019
The National Institute of Allergy and Infectious Diseases, part of the NIH, has launched a trial investigating the safety and efficacy of delamanid for the prevention of…
More Headlines »

Neonatal Tuberculosis

Pediatric Annals, May 2015, Volume 44 Issue 5
Tuberculosis remains a prevalent disease worldwide, with approximately 9 million cases diagnosed annually. The…
More »
Meeting News Coverage

VIDEO: Mel Spigelman, MD, discusses TB drug pipeline

June 19, 2016
More »
Healio Jobs